濮阳东方医院妇科口碑很好放心濮阳东方男科医院割包皮口碑非常好,濮阳东方妇科具体位置在哪,濮阳东方医院做人流费用,濮阳东方男科医院坐公交路线,濮阳东方医院男科治疗早泄评价比较高,濮阳市东方医院收费查询,濮阳东方妇科医院口碑评价很好

The White House has approved a disaster declaration for Shasta County, California, where officials say the massive Carr Fire has killed seven people and is continuing to burn through homes and property.The death toll in the Carr Fire reached seven Saturday when a Pacific Gas & Electric worker was killed while working with a crew to restore power in western Shasta County, utility spokesman J.D. Guidi said. An eighth fire-related death occurred in the Ferguson Fire, east of San Jose, when Capt. Brian Hughes of the Arrowhead Interagency Hotshot Crew was killed.In a statement announcing the White House's approval Saturday, Gov. Jerry Brown said California had submitted the request for a Presidential Major Disaster Declaration earlier that day to help with the impact of fires across the state. 811

The US Food and Drug Administration has again expanded the list of recalled medications that contain valsartan, used as a component in a set of drugs to treat heart failure and blood pressure.The expanded list was posted Monday.The FDA announced an initial recall in July after lab tests revealed that some drugs could have been tainted with a substance that may lead to a higher risk of cancer. The drug had been recalled in 22 other countries.The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide, but not all drugs containing valsartan are affected. 594

The summer of 2020 has been one marred by civil unrest in the U.S. Since the death of George Floyd at the hands of police on Memorial Day weekend, thousands of protests have taken place across the country calling for police reform and an end to systemic racism.While some of those protests have resulted in burned buildings and looted businesses, a non-profit group reports that the overwhelming majority of Black Lives Matter protests in 2020 have been peaceful.According to a report from the Armed Conflict Location and Event Data Project (ACLED), there were nearly 8,000 demonstrations linked to the Black Lives Matter movement between May 26 and Aug. 22 — 93% of which were peaceful.The ACLED, which sources information via reports from the media, reports from government and non-government agencies as well as targeted social media reports, says that Black Lives Matter protests took place in more than 2,000 locations — including in all 50 states — between late May and August. Most places that saw protests that devolved into riots also saw several other peaceful demonstrations.The organization also notes that in places where riots were widespread, like Portland, that the vandalism was limited to the span of a few square blocks.The ACLED's findings contradict the findings of pollsters, who report that as many as 42% of Americans believe most Black Lives Matter activists are "trying to incite violence or destroy property." The ACLED believes that disparity comes from "biased media framing" stemming from "disproportionate coverage of violent demonstrations."And while BLM demonstrations have been largely peaceful, the ACLED reports that local governments have disproportionately responded with force. About 1 in 10 BLM protests were met with government intervention — a 6% increase when comparing government intervention in all other demonstrations. In half of those interventions, police used tear gas, rubber bullets, pepper spray or batons while attempting to force protesters to disperse.While not the case in every violent protest, the ACLED reports that some riots were instigated by "agents provocateurs," or outside infiltrators. For example, a man with an umbrella who committed early acts of vandalism in Minneapolis has since been linked to Hells Angels.The Black Lives Matter protests have also sparked a conversation about statues dedicated to Confederate leaders or those with colonialist or slave-owning pasts. The ACLED found 38 instances in which protesters toppled such statues, though local governments across the country have peacefully removed dozens of similar monuments on their own.The ACLED aggregates data from political conflicts around the world. According to the group's webpage, the non-profit organization receives some funding from the State Department. 2810

The US Food and Drug Administration has raised alarm about one way people might access opioids to misuse and abuse: their pets.As America's opioid epidemic rages, some pet owners could be stealing pain medications intended for their furry friends, according to a statement from FDA Commissioner Dr. Scott Gottlieb."We recognize that opioids and other pain medications have a legitimate and important role in treating pain in animals -- just as they do for people," Gottlieb said in Wednesday's statement."But just like the opioid medications used in humans, these drugs have potentially serious risks, not just for the animal patients, but also because of their potential to lead to addiction, abuse and overdose in humans who may divert them for their own use," he said.Gottlieb also said there hasn't been much information about responsible opioid prescribing for veterinary medicine professionals, and so the FDA developed a resource guide on what veterinarians need to know.The resource includes information on state and federal regulations, alternatives to opioids and how to properly safeguard and store opioids, as well as how to identify if a client or employee may be abusing opioids and take action with a safety plan."While each state creates its own regulations for the practice of veterinary medicine within its borders, including regulations about secure storage of controlled substances like opioids, veterinarians should also follow professional standards set by the American Veterinary Medical Association in prescribing these products to ensure those who are working with these powerful medications understand the risks and their role in combatting this epidemic," Gottlieb said."Veterinarians are also required to be licensed by the Drug Enforcement [Administration] to prescribe opioids to animal patients, as are all health care providers when prescribing for use in humans," he said."These measures are in place to help ensure the critical balance between making sure animals can be humanely treated for their pain, while also addressing the realities of the epidemic of misuse, abuse and overdose when these drugs are diverted and used illegally by humans."The FDA statement came one week after a perspective paper in the American Journal of Public Health called for the veterinary, public health, pharmaceutical and regulatory communities to dedicate time and resources to addressing the issue of prescription opioid diversion in veterinary medicine."I was thrilled to see the FDA commissioner make a statement that not only validated our findings but also demonstrates why research is so important for good policy," said Liliana Tenney, a senior instructor with the Colorado School of Public Health at the University of Colorado Anschutz Medical Campus and deputy director of the Center for Health, Work & Environment, who was a co-author of the paper.Tenney was unaware of the FDA statement until CNN contacted her for an interview, she said.The paper included data from a 24-item online survey that 189 veterinarians in Colorado completed in collaboration with a local veterinary society. The survey, which was about the possible abuse and misuse of opioids by pet owners and the role veterinarians play in prevention, was administered in summer 2016, Tenney said.The survey results showed that 13% of the veterinarians were aware that an animal owner had intentionally made an animal ill or injured -- or seem to be ill or injured -- to obtain opioid medications."This is significant for two reasons. These providers want to ensure the treatment of pets," Tenney said. "If this is truly the case and pet owners are intentionally harming animals, that's an animal rights issue. If opioids are being prescribed and aren't getting to the pets that need them because these drugs are being diverted, that's a public health issue."The survey results also showed that 44% of the veterinarians were aware of opioid abuse or misuse by either a client or a veterinary practice staff member, and 62% believed that they had a role in preventing opioid abuse and misuse."We recognize that this ... sample, representing 10% of the society's members, has limited generalizability and cannot be used to extrapolate to all practices. Nonetheless, these data are sufficient to warrant immediate action," the authors wrote.American Veterinary Medical Association spokesman Michael San Filippo emphasized in a statement Wednesday that the association has provided resources for veterinary staff to help combat this issue and the association will continue to monitor the situation."Though our animal patients are not the ones struggling with opioid addiction, concerns about misuse and diversion are top-of-mind for the veterinary profession, and the AVMA is actively involved in providing resources to practitioners describing alternative ways to treat pain and minimize opioid use," the statement said."While the limited data available suggests diversion from veterinary practices isn't a widespread problem, that doesn't mean we should pretend it doesn't exist," it said. "In fact, AVMA policy calls for further research to determine the prevalence of veterinary drug shoppers and to further clarify the degree to which veterinary prescriptions are impacting, or not, the human opioid epidemic."? & ? 2018 Cable News Network, Inc., a Time Warner Company. All rights reserved. 5456

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.Alongside the tablets, the agency also approved a diagnostic to detect the mutation."Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.Both treatments were granted Priority Review designation.Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review."A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.Both treatments also received?orphan drug?designation, a status granted to drugs for rare diseases or conditions. 2261